tocilizumab,cevostamab
roche
['mmsm', 'tocilizumab', 'toci', 'cevostamab']
pretreatment with tocilizumab prior to cevostamab in patients with rrmm crs (35.7% vs 90.9%) no difference in response rate #mmsm #bite #ash22 
Washington U. School of Medicine.
Assoc Director Hem/Onc Fellowship.
Myeloma, Amyloidosis, Leukemia, Lymphoma & BMT physician and researcher.
Tweets are my own.